Background : This study aimed to identify the mechanisms of the antinociceptive effects of PG in the fibromyalgia (FM)-like animal model. Methods and Results : To assess the possible effect of PG on FM symptoms, we constructed a FM animal model induced by intermittent cold stress with slight modification. All mice underwent nociceptive assays using electronic von Frey anesthesiometer and Hargreaves equipment. To assess the relation between PG and the expression levels of brain-derived neurotrophic factor (BDNF), cAMP response element-binding protein (CREB), and phosphorylated CREB (p-CREB), western blotting and immunohistochemistry analyses were performed. In behavioral analysis, nociception tests showed that the pain threshold was significantly decreased in the FM group compared to control group. Western blot and immunohistochemical analyses of the medial prefrontal cortex and hippocampus showed downregulation of BDNF and p-CREB proteins in the FM group compared to control group. PG recovered these changes at behavioral tests and protein level. These results provide evidence that the effects of PG extract in the FM model may be related to its modulating effect on the BDNF signaling pathway in the hippocampus and medial prefrontal cortex. Conclusion : Our animal model may be involved in the mechanism by which PG extract is effective as a therapeutic agent for FM.

Background: Prenatal exposure to infectious and/or inflammatory insults can increase the risk of developing neuropsychiatric disorder such as bipolar disorder, autism, and schizophrenia later in life. We investigated whether Valeriana fauriei (VF) treatment alleviates prepulse inhibition (PPI) deficits and social interaction impairment induced by maternal immune activation (MIA).Methods and Results: Pregnant mice were exposed to polyriboinosinic-polyribocytidilic acid (5㎎/㎏, viral infection mimic) on gestational day 9. The adolescent offspring received daily oral treatment with VF (100㎎/㎏) and injections of clozapine (5㎎/㎏) for 30 days starting on the postnatal day 35. The effects of VF extract treatment on behavioral activity impairment and protein expression were investigated using the PPI analysis, forced swim test (FST), open field test (OFT), social interaction test (SIT), and immunohistochemistry. The MIA-induced offspring showed deficits in the PPI, FST, OFT, and SIT compared to their non MIAinduced counterparts. Treatment with the VF extract significantly recovered the sensorimotor gating deficits and partially recovered the aggressive behavior observed in the SIT. The VF extract also reversed the downregulation of protein expression induced by MIA in the medial prefrontal cortex.Conclusions: Our results provide initial evidence of the fact that the VF extract could reverse MIA-induced behavioral impairment and prevent neurodevelopmental disorders such as schizophrenia.